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ABSTRACT
RNA aptamers that bind the opium alkaloid codeine
were generated using an iterative in vitro selection
process. The binding properties of these aptamers,
including equilibrium and kinetic rate constants,
were determined through a rapid, high-throughput
approach using surface plasmon resonance (SPR)
analysis to measure real-time binding. The approach
involves direct coupling of the target small molecule
onto a sensor chip without utilization of a carrier
protein. Two highest binding aptamer sequences,
FC5 and FC45 with Kd values of 2.50 and
4.00 mM, respectively, were extensively studied.
Corresponding mini-aptamers for FC5 and FC45
were subsequently identified through the described
direct coupling Biacore assays. These assays were
also employed to confirm the proposed secondary
structures of the mini-aptamers. Both aptamers
exhibit high specificity to codeine over morphine,
which differs from codeine by a methyl group.
Finally, the direct coupling method was demon-
strated to eliminate potential non-specific interac-
tions that may be associated with indirect coupling
methods in which protein linkers are commonly
employed. Therefore, in addition to presenting the
first RNA aptamers to a subclass of benzyliso-
quinoline alkaloid molecules, this work highlights a
method for characterizing small molecule aptamers
that is more robust, precise, rapid and high-
throughput than other commonly employed
techniques.
INTRODUCTION
Codeine is a naturally-occurring opium alkaloid, part of the
larger class of benzylisoquinoline alkaloids (BIAs), found
in the opium poppy, Papaver somniferum, and constitutes
 0.5% of opium (1). It is one of the most widely used
narcotic drugs for the treatment of mild to moderate pain,
diarrhea and cough with relatively low side effects (2).
Despite its extensive medical applications, codeine is often
abused for its euphoric and depressant effects as well as to
prevent opiate withdrawal (3). Due to increasing misuse,
codeine has been incorporated into workplace and military
drug testing programs, and a screening and conﬁrmation
cut-off concentration of 40 mg/l has been suggested for
federally-mandated testing in oral ﬂuid by the Substance
Abuse and Mental Health Services Administration (3). There-
fore, a sensor system that can precisely measure the concen-
tration of codeine and effectively discriminate against its
structural analogues is highly desired.
Aptamers are nucleic acid molecules that bind ligands with
high speciﬁcity and afﬁnity (4). There is increasing interest in
utilizing aptamers as the target recognition elements in
various sensing applications (5–8). In addition to the drug
detection applications of a codeine-binding aptamer, there
are other potential biotechnology applications for this
aptamer. Codeine is a member of the BIA family and is a
key product metabolite in the opium alkaloid biosynthesis
pathway (9). The BIAs comprise a structurally diverse
group of pharmacologically important compounds (10) and
efforts are ongoing to engineer microbial and plant hosts
for the production of some of the important BIA intermedi-
ates in the codeine synthesis pathway, such as (S)-reticuline
and thebaine (9–11).
Aptamers to BIA molecules may prove to be useful tools
for such engineering efforts. Recent research has highlighted
the application of aptamers as components of synthetic and
naturally-occurring cellular sensors and switches (12–17),
which can regulate enzyme levels in response to small
molecule ligand concentrations. Therefore, aptamer-based
cellular sensors may be generated to act as ‘intelligent’
regulatory tools for metabolic engineering efforts to provide
dynamic regulation of gene expression at speciﬁc enzymatic
steps so that pathway ﬂuxes are rewired to enable the
accumulation of desired intermediate metabolites, which
has proven to be difﬁcult to achieve in natural plant
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doi:10.1093/nar/gkl718hosts (9). A codeine-binding aptamer may be used to con-
struct tools, such as synthetic riboswitches that can be
employed to redirect ﬂux through an engineered BIA meta-
bolic pathway or in setting up rapid functional screens of
pathway variants. In addition, while aptamers have been
developed to several of the far upstream metabolites in this
pathway, such as dopamine (18) and tyrosine (19), they
have not yet been developed against any BIA compounds,
which harbor bulky, nitrogen-containing ring structures.
Prior work has demonstrated that aptamers to speciﬁc mole-
cules within a family of compounds may be used to design
doped libraries for the selection of aptamers to similar com-
pounds within that family from smaller library sequence
spaces (19), and thus codeine aptamers would be potentially
useful for selecting aptamers to diverse BIA molecules.
This work describes the generation of novel RNA aptamers
to the small molecule codeine and highlights a robust, high-
throughput assay method for measuring small molecule-
aptamer binding properties. RNA aptamers that bind codeine
with high afﬁnities were selected from a combinatorial library
containing a 30 nt randomized region using an iterative
in vitro selection procedure or SELEX (Systematic Evolution
of Ligands by EXponential enrichment) (20,21). The binding
properties of the generated codeine aptamers were measured
by surface plasmon resonance (SPR) through a real-time
binding assay (Biacore), similar to previously reported
methods (22,23) where the small molecule ligand is directly
coupled to a sensor chip through chemical modiﬁcation of the
ligand, eliminating the need to use protein linkers between
the target small molecule and the sensor surface as described
in other methods (24–26). This direct coupling method limits
potential non-speciﬁc interactions or binding artifacts arising
from the presence of the linker protein observed in previous
studies (24,25), which may alter the determined binding
afﬁnities. Therefore, this method may provide a more
accurate assessment of small molecule-aptamer binding
afﬁnities since the measured interaction more closely mimics
the binding environment of the in vitro selection process.
MATERIALS AND METHODS
DNA template library preparation
A random DNA library was generated through PCR using the
following oligonucleotide sequences: a 59 nt DNA template
50-GGGACAGGGCTAGC(N30)GAGGCAAAGCTTCCG-30,
primer1 50-TTCTAATACGACTCACTATAGGGACAGGGC-
TAGC-30 and primer2 50-CGGAAGCTTTGCCTC-30. All
DNA synthesis was performed by Integrated DNA Technolo-
gies, Inc. The template contains a 30 nt randomized region
ﬂanked by two ﬁxed primer-binding regions (Figure 1A).
Primer1 contains a 17 nt T7 promoter sequence (italic).
NheI and HindIII restriction endonuclease sites (underlined)
were included in primer1 and primer2, respectively, for
cloning of aptamer sequences.
Codeine coupling and affinity chromatography
matrix preparation
Approximately 300 mg of epoxy-activated Sepharose 6B
(GE Healthcare) was hydrated and incubated with 2.5 mM
codeine in coupling buffer [0.05 M Na2PO4 (pH 13)] over-
night at 37 C according to the manufacturer’s instructions.
The coupled medium was washed three times with 2 ml of
coupling buffer to remove uncoupled codeine. The medium
was then incubated overnight with 1 M Tris–HCl (pH 8) at
40 C to block any remaining active groups. Finally, the
medium was washed with a solution containing 0.1 M
NaOAc (pH 4) and 0.5 M NaCl followed by a second solution
containing 0.1 M Tris–HCl (pH 8) and 0.5 M NaCl. The wash
was repeated twice and the matrix was resuspended in 10 mM
Tris–HCl (pH 8) and stored at 4 C. The codeine afﬁnity
chromatography matrix was prepared by packing the coupled
medium (500 ml) into a column following the manufacturer’s
instructions (Pierce). The packed column was washed with 10
column volumes of binding buffer [250 mM NaCl, 20 mM
Tris–HCl (pH 7.4) and 5 mM MgCl2] and equilibrated prior
to the selection process.
Initial RNA library pool preparation
The initial DNA library pool was generated by PCR con-
ducted for 12 cycles on a mixture (100 ml) containing
20 pmol DNA template, 300 pmol each primer1 and primer2,
200 mM each dNTPs, 1.6 mM MgCl2, and 10 U Taq DNA
polymerase (Roche). This DNA library pool ( 1.2 · 10
14
molecules) was transcribed into an initial RNA library pool
by incubating overnight at 37 C in the presence of 40 mM
Tris–HCl (pH 7.9), 16 mM MgCl2, 10 mM DTT, 2 mM
spermidine, 3 mM each rNTPs, 50 mCi [a-
32P]UTP
(GE Healthcare), 500 U RNase inhibitor and 50 U T7 RNA
polymerase (New England Biolabs). The DNA template
was subsequently degraded by incubating the reaction mix-
ture with 10 U of DNase I (Invitrogen) at 37 C for 15 min.
The unincorporated nucleotides were removed with a
NucAway spin column (Ambion) following the manufac-
turer’s instructions and binding buffer was added to the
ﬂow-through RNA to bring the total volume up to 500 ml.
In vitro selection of codeine-binding aptamers
Prior to incubation with the codeine-modiﬁed afﬁnity col-
umn, the RNA pool was denatured at 70 C for 3 min and
allowed to renature at room temperature for 30 min. To elimi-
nate RNA molecules that non-speciﬁcally bind to the column
matrix, the initial pool was ﬁrst incubated with an unmodiﬁed
column. The ﬂow-through fraction from this incubation was
subsequently transferred to a codeine-modiﬁed afﬁnity col-
umn and incubated for 45 min. Following the incubation
period, the afﬁnity column was washed with 10 column
volumes of binding buffer for cycles 1 to 5 to remove
unbound RNAs. This wash volume was increased 10 column
volumes for each of the subsequent cycles. Bound RNA was
eluted with 7 column volumes of 5 mM codeine in binding
buffer. The eluted RNA was recovered by ethanol preci-
pitation in the presence of 20 mg/ml glycogen. Reverse trans-
cription and cDNA ampliﬁcation (15 PCR cycles) were
performed in a single step using 200 U of SuperScript III
reverse transcriptase (Invitrogen) and 5 U of Taq DNA
polymerase in a 50 ml reaction volume. One-ﬁfth of this
DNA library was transcribed into an RNA library pool for
the subsequent selection cycle. A total of 15 selection cycles
were carried out during the in vitro selection process.
Nucleic Acids Research, 2006, Vol. 34, No. 19 5671Figure 1. Aptamer clone sequences. (A) DNA template from which the initial RNA pool was generated. (B) Sequences of clones from the final aptamer pool.
The codeine-binding properties of the sequences marked with an asterisk were characterized by the described direct coupling SPR assay. The number in
parenthesis represents the frequency of a particular clone in the sequenced pool.
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was performed by eluting the bound RNA with 3 column
volumes of 5 mM morphine in binding buffer prior to elution
with codeine. Only RNA eluted with codeine was used to
make the input DNA library pool for the subsequent selection
cycle. Following the reverse transcription step of cycles 11,
12 and 13, an error-prone PCR was performed in a mutagenic
buffer containing 40 pmol each primer1 and primer2, 7 mM
MgCl2, 50 mM KCl, 10 mM Tris–HCl (pH 8.3), 0.2 mM
dGTP, 0.2 mM dATP, 1 mM dCTP, 1 mM dTTP and
0.5 mM MnCl2. One-ﬁfth of the error-prone PCR product
from each of these cycles was used as the input DNA library
pool for the subsequent selection cycle.
Aptamer library sequence analysis
The DNA pool from cycle 15 was ampliﬁed by PCR and
cloned into a plasmid using the NheI and HindIII restriction
sites present in the ﬁxed regions of the aptamer sequence
and the plasmid construct. This plasmid library was trans-
formed into an electrocompetent Escherichia coli strain,
DH10B (Invitrogen; F- mcrA D(mrr-hsdRMS-mcrBC)
f80dlacZDM15 DlacX74 deoR recA1 endA1 araD139
D(ara, leu)7697 galU galK l- rpsL nupG). Subcloning was
conﬁrmed by colony PCR, and a total of 58 positive colonies
were sequenced by Laragen, Inc. The resulting sequences
were aligned using the ClustalX sequence alignment program.
Qualitative binding affinity assay
Radiolabeled RNA was prepared from  1 mg of the ﬁnal
DNA pool (cycle 15) in the presence of 40 mM Tris–HCl
(pH 7.9), 14 mM MgCl2, 10 mM DTT, 2 mM spermidine,
3 mM each rAGC mix, 150 mM rUTP, 50 mCi [a-
32P]UTP,
40 U RNase inhibitor and 50 U T7 RNA polymerase. After
allowing the transcription reaction to proceed for 3 h at
37 C, 5 U of DNase I were added to the mixture and the
reaction was incubated for 15 min. The unincorporated
nucleotides were removed with a NucAway spin column
and the ﬂow-through RNA was divided equally into two
volumes. One of the radiolabeled RNA pools was incubated
with a codeine-modiﬁed column, whereas the other pool
was incubated with an unmodiﬁed column. After a 15 min
incubation, each column was washed with 3 column volumes
of binding buffer followed by elution with 7 column volumes
of 5 mM codeine in binding buffer. The eluted RNA from
each column was separated by electrophoresis on an 8%
polyacryamide/7 M urea gel in 1· Tris–borate buffer. The
gel was dried and the recovered radiolabeled RNA was
imaged on a FX phosphorimager (BioRad).
Quantitative direct coupling small molecule-aptamer
binding assay
A CM5 sensor chip was primed with RNase-free water fol-
lowed by preconditioning with a 50 mM sodium hydroxide,
0.1% hydrochloric acid, 0.1% (w/v) SDS, 0.085% phosphoric
acid solution prior to immobilization of codeine onto the chip
surface. The chip was subsequently activated with a 0.2 M N-
ethyl-N0-(dimethylaminopropyl)carbodiimide (EDC), 0.05 M
N-hydroxysuccinimide (NHS) solution. An amine surface
was created by injecting a solution of 0.1 M 1,8-
diaminooctane dissolved in 50 mM sodium borate (pH 8.5)
over the activated sensor chip at 5 ml/min for 10 min.
In order to couple codeine to the amine surface, codeine
was modiﬁed at its hydroxyl group with a succinimidyl
group by placing 10 mM codeine in a pyridine solution
containing 40 mM disuccinimidyl carbonate and 40 mM
4-dimethylamino pyridine. This modiﬁcation reaction was
allowed to take place for 30 min and the reaction mixture
was subsequently diluted with 100 mM sodium borate
(pH 7.0) in a 1:1 v/v ratio. Trenbolone (Figure 2B), a small
molecule structurally distinct from codeine, was modiﬁed in
the same manner for use as a background response. The
modiﬁed trenbolone and codeine molecules were separately
coupled onto ﬂow cells 1 and 2 of the sensor chip, respec-
tively, by alternating injections for 7 min at 5 ml/min for a
total of 28 min for each molecule. After ligand coupling,
the chip was deactivated with 1 M ethanolamine (pH 8.5)
and primed twice with binding buffer.
RNA samples (initial pool, ﬁnal pool and randomly-
selected individual sequences from the ﬁnal pool) were
prepared for Biacore analysis using the Ampliscribe T7
High Yield Transcription Kit (Epicentre) following the
manufacturer’s instructions. Samples were sequentially
injected over the sensor surface for 1.5 min at 5 ml/min
with a 2 min dissociation time. For each sample, various
RNA concentrations were injected by serially diluting sam-
ples from 48 to 0.375 mM along with two blank samples
containing just binding buffer for use as double referencing.
After each run, the surface was regenerated with 10 mM
EGTA for 2 min at 5 ml/min. The raw data were processed
and analyzed to determine the binding constant for each
aptamer using Scrubber (Biologic Software, Pty, Australia,
http://www.cores.utah.edu/interaction/).
Isocratic affinity elution and specificity assays
Radiolabeled FC5 and FC45 RNA were prepared using the
Ampliscribe T7 High Yield Transcription Kit with minor
modiﬁcations to the manufacturer’s instructions (3 mM
each rATP, rCTP, rUTP, 150 mM rGTP and 50 mCi
[a-
32P]GTP). After 3 h of incubation, DNase I was added
to the transcription mixture and the reaction was incubated
at 37 C for 15 min. Unincorporated nucleotides were
removed with a NucAway spin column.
Isocratic afﬁnity elution assays were performed on radiola-
beled FC5 and FC45 as described previously (27,28). The
binding afﬁnities to codeine and morphine in solution were
determined using the following equation: Kd ¼ [Lel] ·
(Vel   Vn)/(Ve   Vel), where Lel is the free ligand concentra-
tion used to elute bound RNA, Vel and Ve are the elution
volumes for RNA in the presence and absence of free ligand
in binding buffer, respectively, and Vn is the column void
volume.
Speciﬁcity assays were performed by equally dividing the
ﬂow-through radiolabeled FC5 and FC45 into three
Sepharose columns (300 ml) modiﬁed with codeine. After a
30 min incubation, each column was washed with 7 column
volumes of binding buffer. Columns were then eluted with a
5 mM solution of the different targets (codeine, morphine or
thebaine) in binding buffer, and 5 column volumes of the
elution were collected. Collected samples were added to
10 ml of Safety-Solve scintillation liquid (Reseach Products
Nucleic Acids Research, 2006, Vol. 34, No. 19 5673International Corp.) and radioactivity levels were measured
on a liquid scintillation counter (Beckman Coulter).
Truncation experiments
Two full-length aptamers with the lowest determined Kd
values were truncated primarily into four different sequences
containing distinct regions of their parent sequences: (i) the
random region (Ran), (ii) the cloning region (Cln), (iii) the
random region and the 50 constant terminus (L) and (iv) the
random region and the 30 constant terminus (R). Predicted
secondary structures formed by these truncated sequences
were examined using mfold (29) and RNAstructure (http://
rna.chem.rochester.edu/RNAstructure.html). Sequences that
adopt well-deﬁned secondary structures were selected for
subsequent Kd determination through the described small
molecule-aptamer binding afﬁnity SPR assay.
Structural probing assay
Structural probing of the FC5 and FC45 full-length aptamers
was performed using a lead ion cleavage assay as described
by Berens et al. (30) with the following slight modiﬁcations.
50 end labeled RNA was incubated in binding buffer contain-
ing 0–250 mM codeine and 0.5 mM lead (II) acetate. After a
15 min incubation, the cleavage reactions were stopped by
adding 0.5 mM EDTA and 1 mg/ml glycogen and the cleaved
RNA was recovered by ethanol precipitation. Radiolabeled
RNA was also subject to RNase T1 cleavage (Ambion) and
alkaline hydrolysis (Ambion) following the manufacturer’s
instructions to be used as ladders. The recovered RNA
samples were separated by electrophoresis on a 10%
polyacryamide/8 M urea gel in 1· Tris–borate buffer. The
gel was dried and the RNA cleavage patterns were imaged
with an FX phosphorimager (BioRad).
Dopamine aptamer binding assay
For direct coupling of dopamine to the sensor surface, a CM5
sensor chip was activated with EDC/NHS as described above.
Following the EDC/NHS activation step, a 10 mM dopamine,
50 mM sodium borate (pH 8.5) solution was injected over
the activated sensor surface for 30 min at 5 ml/min to couple
dopamine to the surface through its amino group. This is the
same chemistry used in the selection of dopamine-binding
aptamers described by Mannironi et al. (18). After dopamine
immobilization, the sensor surface was deactivated with 1 M
ethanolamine for 10 min at 5 ml/min to block the remaining
unreacted succinimidyl groups. The previously selected
dopamine-binding dopa2 RNA aptamer (18) was synthesized
using a similar transcription procedure as described above.
Various concentrations of this RNA sample were injected
over the dopamine-coupled sensor surface and concentration-
dependent binding responses were recorded and subsequently
analyzed for binding properties as described previously.
For indirect coupling of dopamine to the sensor surface
through a BSA protein linker, a CM5 sensor chip was acti-
vated with EDC/NHS as described above. Following the
EDC/NHS activation step, BSA was injected over the
activated surface at 5 ml/min until a signal of 12 500 response
units (RU) was reached. A 0.2 M EDC and 0.1 M dopamine
Figure 2. Schematics of the codeine-immobilized surfaces used in the in vitro selection process and SPR binding property assay. Illustration of the chemistries
used for codeine coupling to the (A) Sepharose matrix and (B) Biacore CM5 sensor chip surface. Note that the codeine-immobilized sensor surface more closely
mimics that of the affinity matrix used during the aptamer selection process versus coupling methods that employ a protein linker. The asterisk next to the oxygen
group of codeine in (B) represents a succinimidyl group (the same group that is covalently attached to the carboxyl group of the sensor surface after EDC/NHS
activation), which reacts with the amine group of the 1,8-diaminooctane linker. Codeine is thereby immobilized onto the chip surface through the same functional
group used to attach it to the affinity matrix during the selection process. Trenbolone, the negative control molecule, is immobilized to the chip surface through
the same chemistry and its structure is shown in (B).
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30 min at 5 ml/min to couple dopamine to BSA. This chem-
istry couples dopamine to BSA through the same functional
group as in the direct coupling chemistry. The remaining
steps in the indirect coupling method are identical to those
used in the direct coupling method.
RESULTS
Selection of codeine-binding RNA aptamers
A slightly modiﬁed in vitro selection procedure was used to
isolate codeine-binding RNA aptamers from a library of
RNA molecules containing a 30 nt random region ﬂanked
by constant primer-binding sequences (Figure 1A). Aptamers
were selected on a codeine afﬁnity column, which was made
by immobilizing codeine to the epoxy-activated agarose
through its hydroxyl group (Figure 2A). To enhance the
stringency of the selection process, the wash volume was
increased incrementally from cycles 6 to 15. To increase
the speciﬁcity of the selected pool, a counter-selection with
a 5 mM morphine solution was performed at cycle 10 prior
to elution with codeine. In addition, a total of three error-
prone PCR steps were carried out for the DNA template
pools of cycles 11, 12 and 13, respectively, to potentially
introduce sequences that are of slightly diverse nucleotide
composition and search a larger sequence space for higher
afﬁnity binders. After cycle 15, the enriched pool was cloned
and approximately 60 colonies were sequenced.
Sequence analysis of codeine aptamers reveals fairly
conserved motifs
Sequence analysis of the selected clones revealed ﬁve sets
of completely identical sequences, 2 with 1 nt difference
(FC5/B10 and A28/B11), and the rest unique sequences
(Figure 1B). Nucleotide deletions or insertions were observed
in a few clones. No single consensus sequence that is con-
served among the entire population of the selected clones
was discovered. However, several fairly conserved but short
sequences were found to exist in many clones. For instance,
the motif AAGGG is present in over 50% of the sequenced
aptamer population. In addition, most clones contain stretches
of G’s and/or UG’s, which suggests that these stretches may
be critical to codeine-binding. Similarly, none of the selected
clones exhibit obvious predicted structural similarities. It was
also observed that most of the sequences do not possess a pre-
dominant predicted structure based on analysis with folding
programs, such as mfold and RNAstructure, and may adopt
different motifs depending on the inclusion or exclusion of
part or all of the constant regions in the structural analysis.
As a result, further analysis through truncation experiments
was conducted to determine the crucial sequences involved
in codeine-binding for two aptamers (FC5 and FC45) that
exhibited the highest binding afﬁnities of those analyzed.
Qualitative assessment of codeine-binding affinity of the
enriched final pool
The codeine-binding afﬁnity of the ﬁnal pool was qualita-
tively assessed by monitoring eluted levels of the radiola-
beled aptamer pool using codeine afﬁnity chromatography.
Radiolabeled RNA from the enriched pool was incubated
with codeine-modiﬁed and unmodiﬁed columns. The eluted
RNA from each column was run on a polyacrylamide gel
and visualized with a phosphorimager (Supplementary
Figure 1). Signiﬁcantly stronger radioactive signals were
detected in the sample eluted from the codeine afﬁnity col-
umn than that eluted from the unmodiﬁed column, indicating
that the RNA aptamers in the ﬁnal pool are highly enriched
in codeine-binding afﬁnity.
Determination of small molecule-aptamer binding
constants using a direct coupling SPR assay
Quantitative assessment of the codeine-binding properties of
the ﬁnal pool, the initial pool and several aptamers from the
ﬁnal pool was performed using a modiﬁed SPR assay
developed on a Biacore 2000. Previous studies where SPR
was used to determine binding afﬁnities between aptamers
and non-protein targets involved the use of BSA or biotin/
streptavidin as intermediate linkers between the sensor
surface and the target molecules (24,26). Here we employ a
direct coupling approach, similar to a previously described
method (22,23), in which the small molecule target is directly
coupled to the sensor surface without a supporting interme-
diate, such as BSA or biotin/strepavidin. Previous direct
coupling strategies have used target molecules that contain
an amine group (22,23), which is a commonly used functional
group in Biacore sensor chip immobilization strategies.
However, since codeine does not contain an amine group, a
chemical modiﬁcation strategy was developed to directly
couple codeine to the chip surface through its hydroxyl
group. In this coupling strategy codeine is ﬁrst modiﬁed at
its hydroxyl group with an amine-reactive succinimidyl
group. This chemical modiﬁcation enables codeine molecules
to readily react with the amine groups attached to the
activated chip surface (Figure 2B). Trenbolone was also
immobilized onto the sensor surface in the same manner
and used as a negative control molecule. Following the
immobilization of codeine and trenbolone in their respective
ﬂow cells of the sensor chip, serial dilutions of RNA samples
were injected into these ﬂow cells. The response detected
from the trenbolone-immobilized ﬂow cell was used as the
background subtraction in evaluating the binding constants.
An equilibrium binding curve was generated from
concentration-dependent binding response data for each
sample to determine the corresponding Kd value.
The binding data from the SPR assay supports the qualita-
tive binding data obtained from the chromatography-based
assay. The data indicate that there was little to no detectable
binding (Figure 3A) between the initial pool and codeine,
whereas the ﬁnal pool bound codeine with signiﬁcant binding
responses (Figure 3B). The overall Kd value of the ﬁnal pool
was evaluated to be  15 mM, whereas that of the initial pool
was estimated to be in the high millimolar range. This latter
value is only an estimate as no binding curve could be estab-
lished for the initial pool due to its insufﬁcient binding
response. Therefore, codeine-binding afﬁnity of the ﬁnal
pool was enhanced over 1000-fold from that of the initial
pool. The Kd values of the analyzed aptamer clones are listed
in Table 1. Several of the aptamer sequences have Kd values
that are much lower than that of the enriched ﬁnal pool.
Nucleic Acids Research, 2006, Vol. 34, No. 19 5675Two of the highest binding aptamers FC45 and FC5, with Kd
values of 2.50 ± 0.06 mM and 4.00 ± 0.13 mM, respectively,
were subject to further characterization studies (Figure 4).
Despite their similar afﬁnities for codeine, FC5 and FC45
may form different binding pockets since their corresponding
mini-aptamers adopt different predicted secondary structures
supported by structural studies described in a later section. In
addition, FC5 and FC45 exhibit fairly different binding
kinetics (Table 2), where the latter has faster kinetics (both
binding and dissociation) than that of the former. Some
clones, such as FC3, FC13, FC34 and C9 have observed
dissociation constants on the same order as that of FC5,
while other clones, such as FC23, A3, A20, B11, C15 and
C23 exhibit similar dissociation kinetics to FC45 (data not
shown). The kinetic data of the modiﬁed FC5 and FC45
sequences discussed in later sections are also reported in
Table 2.
The afﬁnities of the two highest binding aptamers, FC5 and
FC45, to codeine in solution were also determined through a
standard isocratic afﬁnity elution method (27,28). This
control enables the comparison of the surface-based binding
afﬁnities determined with the described SPR assays to the
solution-based afﬁnities. The determined solution binding
afﬁnity of FC45 (Kd ¼ 4.5 mM) was very similar to its surface
binding afﬁnity (Kd ¼ 2.5 mM), whereas FC5 was determined
to bind free codeine with an  10-fold lower afﬁnity (Kd ¼
47 mM) than that to surface-immobilized codeine (Kd ¼
4.0 mM). For a given aptamer-ligand pair, the binding
Figure 3. Concentration-dependent codeine-binding responses (left) and the corresponding equilibrium binding curve (right) of (A) the initial pool and (B) the
enriched final pool. Codeine was coupled to the sensor chip as described. Serial dilutions of the appropriate RNA sample were injected across the sensor surface
and binding responses were recorded over time. Kinetic rate constants were determined by examining the rate of change of binding response when the RNA
samples were initially injected over the surface until equilibrium responses were reached (kon) and when a solution lacking the RNA sample was injected over the
surface once equilibrium levels were bound to the chip surface (koff). Equilibrium binding constants (Kd) were determined by plotting the equilibrium binding
response versus the RNA sample concentration and calculating the corresponding RNA concentration at which half of the maximal response was achieved.
Binding responses were adjusted for background binding by subtracting responses of the corresponding RNA samples determined from a trenbolone-coupled
sensor surface.
Table 1. Codeine-binding affinities of the full-length aptamer sequences as determined from the direct coupling SPR assay
RNA sample Kd (mM) RNA sample Kd (mM) RNA sample Kd (mM)
Final pool 15.20 ± 0.38 FC27 10.90 ± 0.95 B11 5.80 ± 0.29
Initial pool N/A (high mM) FC34 28.00 ± 1.42 B12 8.80 ± 0.44
FC3 28.60 ± 0.96 FC45 2.50 ± 0.06 C4 78.00 ± 4.15
FC5 4.00 ± 0.13 A3 11.50 ± 0.27 C9 9.17 ± 0.33
FC13 14.50 ± 0.58 A20 13.00 ± 0.65 C12 8.88 ± 0.39
FC17 43.70 ± 1.23 A25 7.23 ± 0.34 C15 7.67 ± 0.26
FC21 23.60 ± 1.22 B2 4.75 ± 0.32 C23 8.18 ± 0.23
FC23 19.10 ± 1.49 B9 5.77 ± 0.36
5676 Nucleic Acids Research, 2006, Vol. 34, No. 19afﬁnities for free target in solution and a target immobilized
onto a solid support may differ, as has been observed in pre-
vious studies (19,31,32). For the aptamers studied here, FC5
shows differing afﬁnities for free and immobilized codeine,
whereas FC45 exhibits similar binding afﬁnities.
Assays reveal distinct specificities of the
codeine-binding aptamers to other
benzylisoquinoline alkaloid targets
The ability of FC5 and FC45 to distinguish between three
similar BIA molecules, codeine, thebaine and morphine,
was determined using a chromatography-based assay. Radio-
labeled RNA aptamers were eluted with codeine, morphine
and thebaine, which are all closely related structural ana-
logues (Figure 5A). Eluted FC5 and FC45 demonstrated
 4- and 6-fold increases in radioactivity counts, respectively
(Figure 5B), when eluted with codeine versus morphine. The
semi-quantitative molecular speciﬁcities of these aptamers
were supported by isocratic afﬁnity elution experiments in
which the solution afﬁnities of these aptamers were deter-
mined and observed to differ by similar magnitudes. The
solution afﬁnity for FC45 was determined to be  4.5 mM
to codeine and 25 mM to morphine, whereas the solution
afﬁnity for FC5 was determined to be  47 mM to codeine
and 212 mM to morphine. These results demonstrate that
the single morphine counter-selection performed during the
in vitro selection process was effective at enhancing the
speciﬁcity of the aptamers in the ﬁnal pool to codeine
over morphine. While aptamers that discriminate between
molecules that differ by a single methyl group have
been described previously for purine alkaloid targets
(33,34), these results indicate that aptamers can exhibit this
level of molecular discrimination in spite of the presence
of the bulky 4 six-membered rings in the BIA targets
examined here.
These assays also demonstrate that these two aptamers
exhibit differing speciﬁcities to thebaine. The eluted FC5
exhibited nearly a 2-fold increase in radioactivity counts
when eluted with thebaine versus codeine, whereas FC45
exhibited an  30% decrease in signal. These results indicate
that FC5 exhibits higher speciﬁcity for thebaine over codeine,
whereas FC45 exhibits higher speciﬁcity for codeine over
thebaine. It should be noted that during the selection process
codeine was coupled to the Sepharose column in such a way
that there was no differentiable functional group between
codeine and thebaine. With the attachment chemistry used
in these studies through the functional group at C5, these
two molecules exhibit conformational differences in that
the former has one double bond in the C5-six-membered
ring, whereas the latter contains two (Figure 5A). These
results suggest that aptamers can potentially perform
molecular discrimination at the level of conformation, as
the difference between these two targets is at the level of
torsional structure of the ring backbone.
Characterization of mini-aptamers that demonstrate
binding affinities similar to the full-length aptamers
Truncation experiments were systematically performed on
the full-length FC5 and FC45 aptamers to identify minimal
aptamer domains, or mini-aptamers. Various truncated
aptamer sequences were characterized for their codeine-
binding properties. Truncated sequences that form well-
deﬁned secondary structures as predicted by mfold or RNAs-
tructure were selected for further analysis. The described SPR
small molecule-aptamer binding assays were employed to
determine the codeine-binding afﬁnities of these truncated
sequences.
An FC5 mini-aptamer was identiﬁed by characterizing
three truncated sequences of the FC5 full-length aptamer.
The codeine-binding properties of the random region
(FC5Ran), which is the N30 region of the aptamer library;
the cloning region (FC5Cln), which includes the random
region, most of the 30 constant terminus, and part of the 50
constant terminus; and FC5L, which includes the random
region and the 50 constant terminus, were analyzed using
the described SPR binding assay. No binding was observed
between FC5Ran and the codeine-immobilized sensor
Figure 4. Equilibrium codeine-binding curves of (A) FC5 and (B) FC45.
Table2. Dissociation rate constants (koff) for codeine binding of the final pool,
FC5, FC45 and their corresponding truncated sequences
RNA sample koff (1/s) % RNA sample koff (1/s) %
Final pool 7.62·10
 3 ± 5.81 Initial pool N/A
FC5 6.50·10
 3 ± 3.78 FC45 1.14·10
 2 ± 3.35
FC5L 6.70·10
 3 ± 2.80 FC45L 1.03·10
 2 ± 3.61
FC5L-S1 6.65·10
 3 ± 2.79 FC45L-S1 6.84·10
 3 ± 3.98
FC5L-S2 6.54·10
 3 ± 2.44 FC45L-S2 2.43·10
 3 ± 3.29
FC5L-S3 4.79·10
 3 ± 5.00 FC45L-S3 2.69·10
 3 ± 2.23
The corresponding association rate constant (kon) is equivalent to koff/Kd.
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sufﬁcient for the codeine-binding properties of this aptamer.
FC5Cln demonstrated a signiﬁcantly reduced afﬁnity to
codeine (Kd ¼ 39.50 ± 2.27 mM), suggesting that the remain-
der of the 50 constant terminus of FC5 may play an important
role in the formation of the correct binding pocket for
codeine. FC5L binds codeine with an afﬁnity similar to that
of its full-length (59 nt) parent sequence (Kd ¼ 4.55 ±
0.14 mM) despite its signiﬁcantly reduced length (41 nt).
These results indicate that FC5L, referred to as FC5 mini-
aptamer, contains the necessary and sufﬁcient sequence
within FC5 for binding codeine (Figure 6A and C).
An FC45 mini-aptamer was identiﬁed by characterizing
two truncated sequences of the FC45 full-length aptamer.
The codeine-binding properties of the cloning region
(FC45Cln), which includes the random region, most of the
30 constant terminus, and part of the 50 constant terminus;
and FC45L, which includes the random region and the 50
constant terminus, were analyzed using the described SPR
binding assay. FC45Ran, harboring the N30 region of
the library, was not analyzed in this set of truncation
experiments, as there was no well-deﬁned secondary structure
predicted for this sequence by mfold or RNAstructure.
FC45Cln did not exhibit binding to codeine, suggesting that
the codeine-binding pocket was not correctly formed within
the secondary structure adopted by this sequence. However,
FC45L (44 nt) binds codeine with an afﬁnity (2.59 ±
0.09 mM) that is almost identical to that of the full-length
FC45 sequence (Figure 6B and D). Therefore, this FC45
mini-aptamer includes the sequence within FC45 required
to form the correct binding pocket for codeine in contrast
to that of FC45Cln.
These truncation experiments support the importance of
the formation of the correct binding pocket for aptamer
molecular recognition capabilities. In addition, both FC5
and FC45 mini-aptamers lack the 30 constant terminal
sequence, indicating that the 30 terminus is not involved in
binding codeine. Secondary structure predictions from
mfold and RNAstructure indicate that the 30 terminus forms
a small hairpin (Supplementary Figure 3C), isolating itself
from the remaining sequences of FC5 and FC45. The
proposed secondary structures of the FC5 and FC45 mini-
aptamers (Figure 6) are supported by the structural
modiﬁcation and structural probing experiments described
in the next section.
Characterization of modified mini-aptamer sequences
supports the proposed secondary structures
The proposed secondary structures of the FC5 and FC45
mini-aptamers do not possess a strong base stem (Figure 6)
in comparison to other reported aptamer structures. For
instance, the tetracycline minimer (30) has a base stem that
is comprised of ﬁve base-pairs, which contribute to the
stability of the overall secondary structure of the minimer.
Sequences lacking strong or stabilized base stems may
adopt a number of possible secondary structures, whereas a
stabilized base stem can signiﬁcantly reduce presumed
structural variability and therefore restrict a given aptamer
sequence to adopt a very few, and in some cases just one,
distinct structures. Therefore, the proposed secondary
structures of the FC5 and FC45 mini-aptamers may be
evaluated by examining the binding properties of these
aptamers modiﬁed with stabilized base stems.
The base stems of the mini-aptamers were modiﬁed with an
extension of GC base pairs to stabilize the proposed structures
of these mini-aptamers. The FC5 mini-aptamer (FC5L) was
stabilized by extending the existing 3 bp stem with two GC
base pairs (Figure 7B), based on the assumption that a few
nucleotides present on each end of the original mini-aptamer
are unessential for codeine-binding. Similarly, the FC45
mini-aptamer (FC45L) was stabilized by extending the base
stem formed by the 50-CUU and 30-GGG pairing with two
GC base pairs (Figure 8B), excluding several nucleotides
from the 50 end. Following the modiﬁcation, the structures
of these stabilized mini-aptamers were further analyzed in
mfold using the DotPlot Partition Function, which conﬁrms
these structures to be the most favorable ones to adopt
among others. The codeine-binding properties of the resulting
mini-aptamers, referred to as FC5L-S1 and FC45L-S1, respec-
tively, were determined using the described SPR assay. FC5L-
S1 and FC45L-S1 were determined to bind codeine with Kd
values of 5.51 ± 0.23 mM and 4.18 ± 0.48 mM, respectively
(Supplementary Figure 2A and B). These results indicate
Figure 5. The FC5 and FC45 aptamers exhibit differing specificities to BIA
structural analogues. (A) Structures of the three BIA molecules, codeine,
thebaine and morphine, used in examining aptamer specificity. (B)
Specificity elution profiles of the FC5 and FC45 aptamers. Radiolabeled
aptamers were incubated with a codeine-modified Sepharose matrix. The
bound aptamers were subsequently eluted with the different BIA targets and
radioactivity levels in the eluted fractions were measured. Radioactivity
levels were normalized with respect to values obtained from the codeine
elutions for each aptamer.
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eine with afﬁnities similar to the corresponding unmodiﬁed
mini-aptamers. Therefore, these results support the proposed
secondary structures of the FC5 and FC45 mini-aptamers
(Figure 6) and that their codeine-binding afﬁnities were mini-
mally affected by extending the original base stems. Structural
probing studies were performed on FC5 and FC45 full-length
aptamers using a standard lead-based cleavage assay to con-
ﬁrm the structures predicted through the SPR analysis.
Lead-induced and RNase T1 cleavage patterns were observed
to be in agreement with the corresponding proposed structures
(Supplementary Figure 4).
The sequence requirements and ﬂexibility of the mini-
aptamer base stems were examined with directed mutational
analysis coupled with characterization of the effects of these
sequence changes on the codeine-binding properties of these
aptamers by the described SPR assays. Two of the three
original base pairs in the base stem of the FC5 mini-aptamer
were replaced with randomly-selected base-pairs (Figure 7C).
This new sequence (FC5L-S2) was determined to bind
codeine with an afﬁnity (Kd ¼ 5.39 ± 0.28 mM) (Supplemen-
tary Figure 2C) comparable to that of the original aptamer
sequence, indicating that while the presence of the base
stem is essential for codeine-binding, its sequence is not.
The sequence space ﬂexibility demonstrated for the aptamer
base stem of FC5L has been reported in other aptamers,
such as the theophylline aptamer (33).
Studies were also conducted to demonstrate that the forma-
tion of the correct binding pocket within a given aptamer
sequence is highly dictated by the formation of the correct
base stem. The base stems of two alternative secondary struc-
tures for the FC45 mini-aptamer were extended with two
GC-pairs to stabilize these proposed secondary structures
(Supplementary Figures 3A and B), in the same way as
previously described for FC45L-S1. Binding assays revealed
that these structures did not bind codeine with as high afﬁnity
as the initially proposed structure. The Kd values of these
alternative FC45 mini-aptamer structures were increased
 10-fold ( 25 mM), indicating that the codeine-binding
pocket may be somewhat disrupted in these structures.
These results indicate that the formation of the correct base
stem can have signiﬁcant inﬂuence on the formation of the
correct binding pocket for aptamer recognition events.
Validation of the direct coupling SPR assay for
characterization of small molecule-aptamer
binding properties
Biacore assays are widely used to study a variety of molecu-
lar interactions, such as RNA–protein and protein–protein
Figure 6. Codeine-binding mini-aptamer characterization. Proposed secondary structures from mfold of (A) the FC5 mini-aptamer (FC5L) and (B) the FC45
mini-aptamer (FC45L), and the corresponding equilibrium codeine-binding curves of (C) FC5L and (D) FC45L.
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range of target molecules, proteins have most often been
used as the primary targets. Although, Biacore assays have
been used to measure the interaction between aptamers and
non-protein targets, these assays often include a carrier or lin-
ker protein between the target and the sensor surface (24,26).
However, signiﬁcant discrepancies have been observed in Kd
values determined from these assays and other commonly
used methods potentially due to the use of a linker protein
between the dextran surface and the small molecule. While
SPR assays in which the small molecule target is directly
coupled to the sensor surface without inclusion of a linker
protein have been reported previously (22,23), the observed
binding properties have not been validated or proven to
potentially eliminate non-speciﬁc interactions or artifacts
that may arise from the presence of a linker protein used in
the assay. Therefore, experiments were conducted to examine
the reproducibility, accuracy and versatility of these direct
coupling assays.
The reproducibility of the assay method was conﬁrmed
through several means. Binding assays were repeated for sev-
eral samples: two randomly-selected sequences (FC34 and
A25), the initial pool, FC5 and FC45. The codeine-binding
afﬁnities determined from these replicate experiments were
nearly identical, thereby conﬁrming the reproducibility of
the assay method (Supplementary Table 1). In addition, the
assay was repeated for the initial pool, FC5 and FC45 such
that the concentration series sets of these samples were
injected into the ﬂow cells in a random order. Consistent
Kd values (data not shown) were obtained from the random-
injection experiments for all three of the tested RNA samples
when compared to the values obtained from injecting them
sequentially from lowest to highest concentrations. These
results demonstrate the reproducibility and the robustness of
this direct coupling assay method. FC45 was used as a
positive control when performing the described assays on
the remainder of the RNA aptamer sequences.
The potential elimination of non-speciﬁc interactions
between an aptamer and the linker protein by the direct
coupling small molecule-aptamer binding assay was demon-
strated on a previously characterized RNA aptamer to a
different small molecule target. The described SPR binding
assay was performed on a previously characterized dopamine
aptamer (dopa2) (18), whose reported Kd value was deter-
mined through commonly used solution-based afﬁnity
methods. Dopamine was immobilized onto the sensor chip
through the same coupling chemistry that was used in the
original selection of this dopamine-binding aptamer. The
binding afﬁnity determined through the direct coupling SPR
assay of the dopa2 RNA aptamer to dopamine (Kd ¼ 2.71
± 0.06 mM) was nearly identical to the reported value of
2.8 mM (18) (Supplementary Figure 5A).
An indirect coupling assay was performed on the dopamine
aptamer using BSA as a protein linker to demonstrate that the
presence of a linker protein in a SPR small molecule-aptamer
binding assay may generate non-speciﬁc interactions or
artifacts. It was observed that aptamer samples at the same
concentrations take considerably longer to reach an equilib-
rium binding response in the BSA linker assay versus the
direct coupling assay, which is indicative of non-speciﬁc
interactions. The two highest concentration samples reached
a near equilibrium response after 50 min of injection,
approximately 33 times longer than that employed in the
direct coupling assay. Data analysis revealed that the aptamer
binding afﬁnity was signiﬁcantly affected and resulted in a
false assessment as the observed Kd value was substantially
higher than the reported value of 2.8 mM (Supplementary
Figure 5B). To better analyze the data, Clamp (35) was
used to ﬁt the kinetic binding responses, as the two highest
concentration samples did not completely reach equilibrium.
Kinetic data analysis suggested that multiple binding events
are present in the BSA linker assay since the data were
well-ﬁt with a multiple binding site model and did not satisfy
a one-to-one binding model (Supplementary Figures 5C and
D). This ﬁnding was further supported by Scatchard plot
analysis, which also suggested this indirect coupling assay
Figure 8. Structural stabilization of the FC45 mini-aptamer. Proposed
secondary structures from mfold of (A) the original FC45 mini-aptamer
(FC45L) and (B) the FC45 mini-aptamer with a stabilized base stem (FC45L-
S1) in which several nucleotides at the termini of the original mini-aptamer
are truncated.
Figure 7. Structural stabilization and sequence requirements of the FC5 mini-
aptamer stems. Proposed secondary structures from mfold of (A) the original
FC5 mini-aptamer (FC5L), (B) the FC5 mini-aptamer with a stabilized base
stem (FC5L-S1), (C) the FC5 mini-aptamer with a stabilized base stem
composed of randomly-selected nucleotides (FC5L-S2).
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in this plot, a hallmark of a multiple binding site model
(Supplementary Figure 5F). In contrast, the direct coupling
data ﬁt a single binding site system represented by a linear
ﬁt to this data (Supplementary Figure 5E). These results
indicate that the presence of a protein linker can cause an
aptamer to bind to its surface-immobilized target molecule
in a non-speciﬁc manner, leading to an inaccurate assessment
of the binding afﬁnity of the aptamer to its small molecule
target.
DISCUSSION
In this study, we employed in vitro selection strategies to
isolate RNA aptamers with high afﬁnity and speciﬁcity to a
subclass of BIA molecules, including codeine, within 15
selection cycles. A counter-selection with morphine and
three error-prone PCR steps were incorporated into the
selection process to enhance the speciﬁcity and afﬁnity of
the selected aptamers for their target molecule. The qualita-
tive binding assays revealed that the ﬁnal aptamer pool was
highly enriched with codeine-binding afﬁnity. The binding
afﬁnity of the enriched aptamer pool was determined to be
15 mM when characterized through the described Biacore
assay; however, several of its member sequences, including
FC5 and FC45, were determined to have higher afﬁnities to
codeine. In addition both of these aptamers were shown to
be highly speciﬁc to codeine over morphine, indicating that
the morphine counter-selection performed during the
selection process was effective at enhancing the desired target
speciﬁcity of the aptamers. Interestingly, while FC45
maintains codeine-binding speciﬁcity over another structural
analogue, thebaine, FC5 demonstrates higher speciﬁcity to
the latter. Therefore, these aptamers exhibit differing speci-
ﬁcities to BIA alkaloid molecules, displaying molecular
discrimination between targets differing by a single methyl
group or structural conformation.
This work also highlights a direct coupling SPR binding
assay for accurately and robustly determining the binding
properties of aptamers to small molecule ligands. The
described method is based on the direct immobilization of
the target small molecule onto the sensor chip surface without
inclusion of a linker protein as is commonly used. This direct
coupling may provide a more accurate assessment of the
binding afﬁnity between the small molecule target and the
aptamer by eliminating potential non-speciﬁc binding
between the nucleic acid aptamer and the protein linker and
more accurately reproducing conditions used in the selection
process. Signiﬁcant discrepancies have been observed
between reported Kd values obtained from Biacore assays
that employ a protein linker connecting the target molecule
to the sensor surface and other methods that involve direct
target coupling. In one example, BSA was used as a linker
between a target carbohydrate and the sensor surface (24).
The binding afﬁnity of a selected aptamer was reported as
85 pM using this assay method. However, when the aptamer
was immobilized onto the sensor surface and target molecules
were injected over the surface, the binding afﬁnity to the
BSA-linked target was similar to that observed with the
earlier experimental setup (Kd ¼ 57 pM), whereas the binding
afﬁnity to the target molecule alone was determined to be
 60-fold lower (Kd ¼ 3.3 nM). In another example, an exist-
ing tobramycin aptamer, characterized with a Biacore binding
assay using a streptavidin linker, showed a lower degree of
selectivity and signiﬁcantly reduced afﬁnity (25) from
previously reported binding properties for this aptamer deter-
mined using a number of different assay methods (36–39).
These results indicate that the presence of a protein linker
may introduce artifacts or non-speciﬁcity in the small
molecule-aptamer interaction, preventing an accurate assess-
ment of the intact afﬁnity of the aptamer to its target
molecule. Direct coupling of the small molecule target onto
the sensor surface may provide a more accurate assessment
of small molecule-aptamer binding properties by eliminating
potential non-speciﬁc interactions or artifacts introduced
when using a linker protein.
The direct coupling SPR small molecule-aptamer binding
assay has the additional beneﬁt of providing a rapid
characterization assay. In comparison to other commonly
used binding assays, such as isocratic elution or equilibrium
ﬁltration, Biacore assays offer a rapid, high-throughput
platform, which provides information about both equilibrium
and kinetic binding properties. Using the Biacore 2000 and
the serial dilution method described in this work, the binding
properties of as many as eight aptamer sequences may be
accurately and precisely determined in one day on a single
chip. It should be noted, that the binding properties deter-
mined through this assay correspond to ligand-immobilized
binding properties, which may differ from free ligand binding
properties depending on the particular aptamer-ligand pair as
demonstrated in this and previous work. However, this high-
throughput assay strategy may be particularly useful when
applied to the screening of libraries for aptamers that exhibit
particular binding properties. From this initial screen, those
aptamers exhibiting desired binding afﬁnities for surface-
immobilized target may be further analyzed with standard
solution afﬁnity assays to determine and verify the corre-
sponding binding afﬁnities of those selected aptamers to
free target in solution. Furthermore, the high-throughput
nature of this platform may be used to rapidly determine
the mini-aptamers for selected aptamers through truncation
experiments, eliminating the need to perform time-consuming
and labor-intensive chemical probing experiments (18,30). In
addition, while traditional binding assays involve the use of
radiolabeled aptamers or often rare and expensive radiola-
beled target molecules, Biacore assays eliminate this require-
ment. The same assay methodology may be employed to
perform structural stabilization studies, which were used to
develop mini-aptamers with stabilized base stems. Aptamers
with stabilized, modiﬁable and extendable base stems are
more functionally attractive for applications in downstream
molecular design strategies that involve exploiting structural
rearrangements associated with the base stem formation (17).
Therefore, the FC5 and FC45 mini-aptamers may be readily
employed in molecular engineering applications as their
stems are extendable and modiﬁable. Finally, the versatility
of this direct coupling SPR assay to the study of small
molecule-aptamer interactions was demonstrated through
several means and validated on a previously characterized
dopamine RNA aptamer. Elimination of non-speciﬁc interac-
tions was demonstrated in the direct coupling assay compared
to the indirect coupling assay for the same aptamer, where
Nucleic Acids Research, 2006, Vol. 34, No. 19 5681non-speciﬁc interactions or binding artifacts arose in the pres-
ence of the linker protein. Therefore, the SPR assay discussed
here is proven to be a rapid, versatile, accurate and robust
method for quantitative measurement of small molecule–
RNA interactions.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
ACKNOWLEDGEMENTS
The authors thank Professor Pamela J. Bjorkman for
generously allowing us the use of the Biacore 2000
instrument, which was used to develop the direct small
molecule-aptamer characterization assays. The authors also
gratefully acknowledge Dr Laure Jason-Moller and William
Hunter (Biacore Life Sciences) and Katie Saliba (Caltech
Chemistry Department) for their technical support and advice
regarding codeine coupling chemistry to the sensor chip. The
authors also thank Dr Kevin Hoff (Caltech Chemical
Engineering Department) for his critical reading of the
manuscript. This work was funded by Caltech startup funds,
the Center for Biological Circuit Design at Caltech (fellow-
ship support for M.N.W.), and the National Institutes of
Health (training grant for J.S.K.).
Conflict of interest statement. None declared.
REFERENCES
1. William,D.G., Hatch,D.J. and Howard,R.F. (2001) Codeine phosphate
in paediatric medicine. Br. J. Anaesth., 86, 413–421.
2. Williams,D.G., Patel,A. and Howard,R.F. (2002) Pharmacogenetics of
codeine metabolism in an urban population of children and its
implications for analgesic reliability. Br. J. Anaesth., 89, 839–845.
3. Kim,I., Barnes,A.J., Oyler,J.M., Schepers,R., Joseph,R.E., Jr,
Cone,E.J., Lafko,D., Moolchan,E.T. and Huestis,M.A. (2002) Plasma
and oral fluid pharmacokinetics and pharmacodynamics after oral
codeine administration. Clin. Chem., 48, 1486–1496.
4. Jayasena,S.D. (1999) Aptamers: an emerging class of molecules that
rival antibodies in diagnostics. Clin. Chem., 45, 1628–1650.
5. Silverman,S.K. (2003) Rube Goldberg goes (ribo)nuclear? Molecular
switches and sensors made from RNA RNA, 9, 377–383.
6. O’Sullivan,C.K. (2002) Aptasensors--the future of biosensing? Anal.
Bioanal. Chem., 372, 44–48.
7. Hesselberth,J.R., Robertson,M.P., Knudsen,S.M. and Ellington,A.D.
(2003) Simultaneous detection of diverse analytes with an aptazyme
ligase array. Anal. Biochem., 312, 106–112.
8. Seetharaman,S., Zivarts,M., Sudarsan,N. and Breaker,R.R. (2001)
Immobilized RNA switches for the analysis of complex chemical and
biological mixtures. Nat. Biotechnol., 19, 336–341.
9. Facchini,P.J. (2001) Alkaloid biosynthesis in plants: Biochemistry, Cell
Biology, Molecular Regulation, and Metabolic Engineering
Applications. Annu. Rev. Plant Physiol. Plant Mol. Biol., 52, 29–66.
10. Allen,R.S., Millgate,A.G., Chitty,J.A., Thisleton,J., Miller,J.A.,
Fist,A.J., Gerlach,W.L. and Larkin,P.J. (2004) RNAi-mediated
replacement of morphine with the nonnarcotic alkaloid reticuline in
opium poppy. Nat. Biotechnol., 22, 1559–1566.
11. Rathbone,D.A. and Bruce,N.C. (2002) Microbial transformation of
alkaloids. Curr. Opin. Microbiol., 5, 274–281.
12. Suess,B., Hanson,S., Berens,C., Fink,B., Schroeder,R. and Hillen,W.
(2003) Conditional gene expression by controlling translation
with tetracycline-binding aptamers. Nucleic Acids Res., 31,
1853–1858.
13. Suess,B., Fink,B., Berens,C., Stentz,R. and Hillen,W. (2004) A
theophylline responsive riboswitch based on helix slipping controls
gene expression in vivo. Nucleic Acids Res., 32, 1610–1614.
14. Werstuck,G. and Green,M.R. (1998) Controlling gene expression
in living cells through small molecule–RNA interactions. Science,
282, 296–298.
15. Desai,S.K. and Gallivan,J.P. (2004) Genetic screens and selections for
small molecules based on a synthetic riboswitch that activates protein
translation. J. Am. Chem. Soc., 126, 13247–13254.
16. Winkler,W.C. and Breaker,R.R. (2005) Regulation of bacterial gene
expression by riboswitches. Annu. Rev. Microbiol., 59, 487–517.
17. Bayer,T.S. and Smolke,C.D. (2005) Programmable ligand-controlled
riboregulators of eukaryotic gene expression. Nat. Biotechnol., 23,
337–343.
18. Mannironi,C., Di Nardo,A., Fruscoloni,P. and Tocchini-Valentini,G.P.
(1997) In vitro selection of dopamine RNA ligands. Biochemistry, 36,
9726–9734.
19. Mannironi,C., Scerch,C., Fruscoloni,P. and Tocchini-Valentini,G.P.
(2000) Molecular recognition of amino acids by RNA aptamers: the
evolution into an L-tyrosine binder of a dopamine-binding RNA motif.
RNA, 6, 520–527.
20. Tuerk,C. and Gold,L. (1990) Systematic evolution of ligands by
exponential enrichment: RNA ligands to bacteriophage T4 DNA
polymerase. Science, 249, 505–510.
21. Ellington,A.D. and Szostak,J.W. (1990) In vitro selection of RNA
molecules that bind specific ligands. Nature, 346, 818–822.
22. Kwon,M., Chun,S.M., Jeong,S. and Yu,J. (2001) In vitro selection of
RNA against kanamycin B. Mol. Cells, 11, 303–311.
23. Gebhardt,K., Shokraei,A., Babaie,E. and Lindqvist,B.H. (2000) RNA
aptamers to S-adenosylhomocysteine: kinetic properties, divalent
cation dependency, and comparison with anti-S-adenosylhomocysteine
antibody. Biochemistry, 39, 7255–7265.
24. Jeong,S., Eom,T., Kim,S., Lee,S. and Yu,J. (2001) In vitro selection of
the RNA aptamer against the Sialyl Lewis X and its inhibition of the
cell adhesion. Biochem. Biophys. Res. Commun., 281, 237–243.
25. Verhelst,S.H., Michiels,P.J., van der Marel,G.A., van Boeckel,C.A. and
van Boom,J.H. (2004) Surface plasmon resonance evaluation of various
aminoglycoside-RNA hairpin interactions reveals low degree of
selectivity. Chembiochem, 5, 937–942.
26. Davis,J.H. and Szostak,J.W. (2002) Isolation of high-affinity GTP
aptamers from partially structured RNA libraries. Proc. Natl Acad. Sci.
USA, 99, 11616–11621.
27. Arnold,F.H. and Blanch,H.W. (1986) Analytical affinity
chromatography II. Rate theory and the measurement of biological
binding kinetics. J. Chromatogr., 355, 13–27.
28. Brockstedt,U., Uzarowska,A., Montpetit,A., Pfau,W. and Labuda,D.
(2004) In vitro evolution of RNA aptamers recognizing
carcinogenic aromatic amines. Biochem. Biophys. Res. Commun.,
313, 1004–1008.
29. Zuker,M. (2003) Mfold web server for nucleic acid folding and
hybridization prediction. Nucleic Acids Res., 31, 3406–3415.
30. Berens,C., Thain,A. and Schroeder,R. (2001) A tetracycline-binding
RNA aptamer. Bioorg. Med. Chem., 9, 2549–2556.
31. Lozupone,C., Changayil,S., Majerfeld,I. and Yarus,M. (2003)
Selection of the simplest RNA that binds isoleucine. RNA, 9,
1315–1322.
32. Majerfeld,I. and Yarus,M. (1998) Isoleucine:RNA sites with associated
coding sequences. RNA, 4, 471–478.
33. Jenison,R.D., Gill,S.C., Pardi,A. and Polisky,B. (1994) High-resolution
molecular discrimination by RNA. Science, 263, 1425–1429.
34. Haller,A.A. and Sarnow,P. (1997) In vitro selection of a
7-methyl-guanosine binding RNA that inhibits translation of capped
mRNA molecules. Proc. Natl Acad. Sci. USA, 94, 8521–8526.
35. Myszka,D.G. and Morton,T.A. (1998) CLAMP: a biosensor kinetic
data analysis program. Trends Biochem. Sci., 23, 149–150.
36. Wang,Y. and Rando,R.R. (1995) Specific binding of aminoglycoside
antibiotics to RNA. Chem. Biol., 2, 281–290.
37. Wang,Y., Killian,J., Hamasaki,K. and Rando,R.R. (1996) RNA
molecules that specifically and stoichiometrically bind
aminoglycoside antibiotics with high affinities. Biochemistry, 35,
12338–12346.
38. Hamasaki,K., Killian,J., Cho,J. and Rando,R.R. (1998) Minimal RNA
constructs that specifically bind aminoglycoside antibiotics with high
affinities. Biochemistry, 37, 656–663.
39. Cho,J., Hamasaki,K. and Rando,R.R. (1998) The binding site of a
specific aminoglycoside binding RNA molecule. Biochemistry, 37,
4985–4992.
5682 Nucleic Acids Research, 2006, Vol. 34, No. 19